Table: Cosmos Pharmaceutical -2022/23 parent results
Jul 10 (Reuters)-
Cosmos Pharmaceutical Corp.
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
May 31, 2023 May 31, 2022 May 31, 2024 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 827.70 755.41
(+9.6 pct)
Operating 30.10 29.77
(+1.1 pct)
Recurring 33.07 32.84
(+0.7 pct)
Net 23.79 23.14
(+2.8 pct)
EPS 600.71 yen 584.40 yen
Ann Div 100.00 yen 80.00 yen 120.00 yen
-Q2 Div 42.50 yen 40.00 yen 60.00 yen
-Q4 Div 57.50 yen 40.00 yen 60.00 yen
NOTE - Cosmos Pharmaceutical Corp..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=3349.T